Etheros Pharmaceuticals

Private

Nashville, TennesseeHealthcare & Life Scienceshttps://etherospharma.com/

Last Round

VC Round

Dec 9, 2025

Total Funding Raised

$950,000

Company Overview

Etheros Pharmaceuticals is a drug discovery company developing a new class of small molecule drugs which mimic endogenous enzymes to prevent oxidative and inflammatory injury.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

catalytic antioxidantssmall molecule drugsneuroprotectionlongevity biotechenzyme mimeticsdrug discovery platformfullerene chemistryneurodegenerative diseasesoxidative stressanti-aging drugshealthspanpre-clinical biotechpharmaceutical partnershipsIND

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Etheros Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Etheros Pharmaceuticals comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Etheros Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Dec 9, 2025
Debt	Jun 10, 2025
Seed	Mar 1, 2023

View all Funding Rounds

Etheros Pharmaceuticals Investors

Notable investors and investment history

Etheros Pharmaceuticals investors
Investor	Rounds
Backed VC	Seed, VC Round
VitaDAO	Seed
Immortal Dragons	VC Round
Healthspan Capital	Seed

View all Investors

Etheros Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Etheros Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Etheros Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersNashville, Tennessee

Year Founded2022

Last FundingDec 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.